Answer
Not automatically. The selected oral solution has a narrower UK licence, for graft-versus-host disease, so any formulation change must be directed by the specialist team.
Sources for this answer
- Jakavi 5mg/ml oral solution — Current selected SmPCemc · Summary of Product Characteristics
- Jakavi 5mg, 10mg, 15mg and 20mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.